City of Hope Medical Center

Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment (2021) Morra A, Escala-Garcia M, Beesley J, Keeman R, Canisius S, Ahearn TU, Andrulis IL, et al. Journal article Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies? (2021) Park J, Choi JY, Choi J, Chung S, Song N, Park SK, Han W, et al. Journal article Associations between genetically predicted circulating protein concentrations and endometrial cancer risk (2021) Zhu J, O’mara TA, Liu D, Setiawan VW, Glubb D, Spurdle AB, Fasching P, et al. Journal article Spartalizumab in metastatic, well/poorly differentiated neuroendocrine neoplasms (2021) Yao JC, Strosberg J, Fazio N, Pavel ME, Bergsland E, Ruszniewski P, Halperin DM, et al. Journal article Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk (2021) Kapoor PM, Mavaddat N, Choudhury PP, Wilcox AN, Lindström S, Behrens S, Michailidou K, et al. Journal article Germline variation in the insulin-like growth factor pathway and risk of Barrett's esophagus and esophageal adenocarcinoma (2021) Dighe SG, Chen J, Yan L, He Q, Gharahkhani P, Onstad L, Levine DM, et al. Journal article Biomarker-guided preemption of steroid-refractory graft-versus-host disease with alpha-1-antitrypsin (2020) Gergoudis SC, Defilipp Z, Ozbek U, Sandhu KS, Etra AM, Choe HK, Kitko CL, et al. Journal article The Magic Biomarker Algorithm Predicts Outcomes for Children with Acute Graft Versus Host Disease (2020) Qayed M, Kapoor U, Gillespie S, Mccracken C, Abusin G, Aguayo-Hiraldo P, Ayuk F, et al. Conference contribution Loss-of-function truncating and missense variants in NSD2 cause decreased methylation activity and are associated with a distinct neurodevelopmental phenotype (2020) Zanoni P, Steindl K, Sengupta D, Sticht H, Joset P, Baar A, Van Ravenswaaij-Arts CMA, et al. Conference contribution Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk (2020) Liu J, Prager-van der Smissen WJ, Collée JM, Bolla MK, Wang Q, Michailidou K, Dennis J, et al. Journal article